诉讼核心信息 - 投资者权利律师事务所Hagens Berman提醒Inspire Medical Systems, Inc. (NYSE: INSP)的投资者注意一项待决的证券集体诉讼[1] - 诉讼指控Inspire Medical及其高管在推出新一代设备Inspire V时隐瞒了关键运营失败从而误导了投资者[1] - 集体诉讼期涵盖在2024年8月6日至2025年8月4日期间购买Inspire Medical (INSP)证券的投资者[2] - 首席原告截止日期为2026年1月5日[3] 指控的核心内容 - 公司曾向投资者保证其已做好Inspire V发布的“运营准备”并准备好进行全面商业推广[3] - 指控称这些保证掩盖了根本性的失败导致发布不可能成功并引发了灾难性的业绩指引削减和股价暴跌[3] - 据称未披露的运营问题使公司的声明在重大方面存在虚假和误导性[4] 具体指控的运营问题 - **医疗保险与计费准备不足**：处理医疗保险索赔所需的软件更新直到2025年7月1日才生效这意味着植入中心无法为手术计费阻碍了早期采用[4] - **旧型号库存过剩**：客户和治疗中心持有大量旧款Inspire IV设备库存影响了新款Inspire V产品的需求并需要进行库存“清理”[4] - **培训与入职不完善**：“许多中心”未完成植入新设备所需的基本培训、合同签订和入职流程[4] 指控的财务与市场影响 - 据称有缺陷的Inspire V发布导致公司将其2025年每股收益(EPS)指引削减了超过80%[4] - 这些问题导致股价单日下跌42.04美元市值缩水32.4%[4] - 律师事务所调查的重点是据称被隐瞒的两个关键点：医疗保险索赔软件故障和旧款Inspire IV设备的库存过剩[5] - 诉讼指控Inspire的股价崩盘是管理层据称优先考虑无缝过渡的叙事而非运营现实的结果[5]

On August 4, 2025, Inspire Medical Systems announced significant setbacks in the launch of its new Inspire V device. The company revealed that the rollout was taking much longer than expected because many treatment centers had not yet completed the required training, contracting, and onboarding needed to begin using the product. Inspire also disclosed billing and reimbursement challenges, explaining that although Medicare had approved a CPT code for Inspire V, the necessary software updates for claims proce ...

CASE DETAILS: According to the filed complaint, defendants made false statements and/or concealed that: In truth, the launch of the Company's new product, Inspire V, was a disaster because demand for Inspire V was poor, as providers had significant amounts of surplus inventory and were reluctant to transition to a new treatment. Moreover—and contrary to defendants' statements assuring investors that Inspire had taken all necessary steps to ensure a successful launch and, later, that the launch was in fact p ...

NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/inspire-medical- ...

NEW YORK, Dec. 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), of the important January 5, 2026 lead plaintiff deadline. SO WHAT: If you purchased Inspire Medical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingenc ...

Inspire's Alleged Fraud NEW YORK--(BUSINESS WIRE)--Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP ("BLB&G†) filed a class action in the U.S. District Court for the Southern District of New York alleging violations of the federal securities laws by Inspire Medical Systems, Inc. ("Inspire†or the "Company†) and certain of the Company's current senior executives (collectively, "Defendants†). The action is brought on behalf of all investors who purchased or otherwise ...

NEW YORK, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Inspire securities between August 6, 2024 and August 4, 2025, b ...

Key Takeaways INSP records strong Inspire V adoption, with most implanting centers trained and already using the new system.Inspire Medical expects to improve reimbursement, including an 11% CMS physician fee increase starting in 2026INSP faces near-term pressure from inventory transition, GLP-1 trialing delays, and elevated operating costs.Inspire Medical Systems (INSP) is well poised for growth in the coming quarters amid a major product transition. Management emphasized clinical momentum behind Inspire V ...

New York, New York--(Newsfile Corp. - December 22, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ ...

NEW YORK, Dec. 22, 2025 /PRNewswire/ --The Gross Law Firm issues the following notice to shareholders of Inspire Medical Systems, Inc. (NYSE: INSP). The Gross Law Firm 15 West 38th Street, 12th floor New York, NY, 10018 Email: [email protected] Phone: (646) 453-8903 ALLEGATIONS: According to the filed complaint, defendants made false statements and/or concealed that: In truth, the launch of the Company's new product, Inspire V, was a disaster because demand for Inspire V was poor, as providers had significa ...